Zoetis Inc
ZTS127.890USD
+5.020+4.09%
Handelsschluss 11/25, 16:00（ET）Kurse um 15 Minuten verzögert
56.46BMarktkapitalisierung
21.30KGV TTM
mehr Informationen über Zoetis Inc Unternehmen
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. It is engaged in commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Zoetis Inc Informationen
BörsenkürzelZTS
Name des UnternehmensZoetis Inc
IPO-datumFeb 01, 2013
CEOMs. Kristin C. Peck
Anzahl der mitarbeiter13800
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 01
Addresse10 Sylvan Way
StadtPARSIPPANY
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl07054
Telefon19738227000
Websitehttps://www.zoetis.com/
BörsenkürzelZTS
IPO-datumFeb 01, 2013
CEOMs. Kristin C. Peck
Führungskräfte von Zoetis Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
25.86K
-6.61%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Dr. Robert J. (Rob) Polzer, Ph.D.
Dr. Robert J. (Rob) Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
6.19K
+0.39%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.19K
+8.28%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
2.82K
+51.75%
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
2.59K
+19.25%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
25.86K
-6.61%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Parasiticides
673.00M
27.36%
Vaccines
504.00M
20.49%
Dermatology
463.00M
18.82%
Anti-infectives
219.00M
8.90%
Pain and sedation
217.00M
8.82%
Andere
384.00M
15.61%
Nach RegionUSD
Name
Umsatz
Anteil
United States
1.36B
55.12%
Other emerging markets
225.00M
9.15%
Other Developed
162.00M
6.59%
Brazil
93.00M
3.78%
Australia
83.00M
3.37%
Andere
541.00M
21.99%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Parasiticides
673.00M
27.36%
Vaccines
504.00M
20.49%
Dermatology
463.00M
18.82%
Anti-infectives
219.00M
8.90%
Pain and sedation
217.00M
8.82%
Andere
384.00M
15.61%
Aktionärsstatistik
Aktualisiert: Sat, Nov 15
Aktualisiert: Sat, Nov 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.55%
BlackRock Institutional Trust Company, N.A.
5.17%
State Street Investment Management (US)
4.46%
State Farm Insurance Companies
3.83%
Geode Capital Management, L.L.C.
2.53%
Andere
74.46%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.55%
BlackRock Institutional Trust Company, N.A.
5.17%
State Street Investment Management (US)
4.46%
State Farm Insurance Companies
3.83%
Geode Capital Management, L.L.C.
2.53%
Andere
74.46%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
49.05%
Investment Advisor/Hedge Fund
32.09%
Research Firm
4.42%
Insurance Company
3.92%
Bank and Trust
2.62%
Pension Fund
2.55%
Hedge Fund
1.56%
Sovereign Wealth Fund
1.25%
Family Office
0.15%
Andere
2.40%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
3275
435.62M
98.29%
-1.39M
2025Q2
3277
434.35M
98.00%
-1.58M
2025Q1
3284
432.42M
97.12%
-4.21M
2024Q4
3199
430.60M
96.14%
-9.58M
2024Q3
3090
434.14M
95.81%
-13.19M
2024Q2
3062
437.75M
95.94%
-9.33M
2024Q1
3060
439.45M
96.16%
-2.63M
2023Q4
3074
438.13M
95.43%
-2.08M
2023Q3
2966
434.04M
94.28%
-3.00M
2023Q2
2949
430.67M
93.19%
-11.77M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
41.69M
9.41%
+326.69K
+0.79%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
22.66M
5.11%
-498.13K
-2.15%
Jun 30, 2025
State Street Investment Management (US)
19.74M
4.45%
-59.31K
-0.30%
Jun 30, 2025
State Farm Insurance Companies
16.84M
3.8%
-34.10K
-0.20%
Jun 30, 2025
Geode Capital Management, L.L.C.
11.08M
2.5%
+95.29K
+0.87%
Jun 30, 2025
Wellington Management Company, LLP
8.89M
2.01%
+2.82M
+46.56%
Jun 30, 2025
Polen Capital Management, LLC
8.42M
1.9%
-375.82K
-4.27%
Jun 30, 2025
Morgan Stanley Investment Management Ltd. (UK)
6.75M
1.52%
+4.58M
+209.96%
Jun 30, 2025
Wells Fargo Advisors
5.83M
1.32%
-180.38K
-3.00%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
5.19M
1.17%
+131.36K
+2.60%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Thu, Nov 6
Aktualisiert: Thu, Nov 6
Name
Anteil
ProShares Pet Care ETF
9.91%
VanEck Agribusiness ETF
7.63%
VanEck Pharmaceutical ETF
4.34%
iShares U.S. Pharmaceuticals ETF
4.32%
Honeytree US Equity ETF
3.92%
First Trust NASDAQ Pharmaceuticals ETF
3.43%
Polen Capital Global Growth ETF
3.35%
iShares ESG Aware MSCI USA Value ETF
3.19%
SPDR S&P Pharmaceuticals ETF
2.35%
Siren DIVCON Dividend Defender ETF
2.07%
Mehr Anzeigen
ProShares Pet Care ETF
Anteil9.91%
VanEck Agribusiness ETF
Anteil7.63%
VanEck Pharmaceutical ETF
Anteil4.34%
iShares U.S. Pharmaceuticals ETF
Anteil4.32%
Honeytree US Equity ETF
Anteil3.92%
First Trust NASDAQ Pharmaceuticals ETF
Anteil3.43%
Polen Capital Global Growth ETF
Anteil3.35%
iShares ESG Aware MSCI USA Value ETF
Anteil3.19%
SPDR S&P Pharmaceuticals ETF
Anteil2.35%
Siren DIVCON Dividend Defender ETF
Anteil2.07%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
2.94B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Dec 12, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Mar 04, 2025 going ex on Jan 21, 2025
Jan 21, 2025
Mar 04, 2025
Jan 21, 2025
Oct 10, 2024
ZTS.NB Final Cash Dividend of gross USD 0.432 paid on Dec 03, 2024 going ex on Oct 31, 2024
Oct 31, 2024
Dec 03, 2024
Oct 31, 2024
May 22, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Sep 04, 2024 going ex on Jul 18, 2024
Jul 18, 2024
Sep 04, 2024
Jul 18, 2024
Feb 06, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Jun 04, 2024 going ex on Apr 18, 2024
Apr 19, 2024
Jun 04, 2024
Apr 18, 2024
Dec 07, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Mar 01, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Mar 01, 2024
Jan 18, 2024
Oct 12, 2023
ZTS.NB Final Cash Dividend of gross USD 0.375 paid on Dec 01, 2023 going ex on Oct 31, 2023
Nov 01, 2023
Dec 01, 2023
Oct 31, 2023
May 11, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Sep 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Sep 01, 2023
Jul 20, 2023
Feb 08, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Jun 01, 2023 going ex on Apr 20, 2023
Apr 21, 2023
Jun 01, 2023
Apr 20, 2023
Dec 08, 2022
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Mar 01, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Mar 01, 2023
Jan 19, 2023
Oct 13, 2022
ZTS.NB Final Cash Dividend of gross USD 0.325 paid on Dec 01, 2022 going ex on Oct 31, 2022
Nov 01, 2022
Dec 01, 2022
Oct 31, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Zoetis Inc?
Die fünf größten Anteilseigner von Zoetis Inc sind:
The Vanguard Group, Inc. hält 41.69M Aktien, was 9.41% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 22.66M Aktien, was 5.11% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 19.74M Aktien, was 4.45% der Gesamtaktien entspricht.
State Farm Insurance Companies hält 16.84M Aktien, was 3.80% der Gesamtaktien entspricht.
Geode Capital Management, L.L.C. hält 11.08M Aktien, was 2.50% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 41.69M Aktien, was 9.41% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 22.66M Aktien, was 5.11% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 19.74M Aktien, was 4.45% der Gesamtaktien entspricht.
State Farm Insurance Companies hält 16.84M Aktien, was 3.80% der Gesamtaktien entspricht.
Geode Capital Management, L.L.C. hält 11.08M Aktien, was 2.50% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Zoetis Inc?
Die drei wichtigsten Anteilseigner-Typen von Zoetis Inc sind:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Wie viele Institutionen halten Anteile an Zoetis Inc (ZTS)?
Mit Stand vom 2025Q3 halten 3275 Institutionen Anteile an Zoetis Inc, mit einem Gesamtmarktwert von etwa 435.62M, was 98.29% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um 0.29% gestiegen.
Was ist die größte Einnahmequelle von Zoetis Inc?
Am FY2025Q2 erzielte das Geschäft mit Parasiticides für Zoetis Inc den höchsten Umsatz in Höhe von 673.00M, was 27.36% des Gesamtumsatzes entspricht.
